Researchers used PET scans and blood psilocin levels to verify that the subjective experiences brought on by psilocybin come from stimulation of the serotonin 5-HT2A receptor.
Magic mushrooms may be synthesizing this newly-discovered compound from baeocystin.
Binding affinity studies show psilocin and psilocybin have different preferences for serotonin receptors.
You may have heard of magic mushrooms or even consumed them. But what are they?
Psilocybin produces more insightful and mystical experiences, but dextromethorphan causes greater feelings of disembodiment.
Data analysis and gene expression maps confirm the role of the 5-HT2A receptor in the effects of LSD.
Researchers push to move psilocybin from Schedule I to Schedule IV if Phase III clinical trials are successful.
Psilocin makes neurons grow faster and produce more connections.
A study in the mouse brain shows serotonin neurons are organized into parallel subsystems.
St Vincent's Hospital of Melbourne, Australia will begin treating patients in April